Literature DB >> 8669459

Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.

T K Yeo1, J A Nagy, K T Yeo, H F Dvorak, B P Toole.   

Abstract

The mouse ovarian ascites tumor, MOT, and mammary ascites tumor, TA3/St, served as models to follow changes in hyaluronan levels during tumor growth, attachment, and invasion. Subsequent to introduction of tumor cells into the peritoneal cavity, hyaluronan accumulated intraperitoneally and at the initial sites of attachment of tumor cells and cell clumps to the mesenteric surface; the latter co-localized with sites of fibrin deposition as reported earlier. Subsequently, high levels of hyaluronan accumulated throughout the interior of the mesentery. Because neither tumor cell line synthesized substantial amounts of hyaluronan in culture, the large accumulations observed in the mesenteries and ascites fluid of tumor-bearing animals most likely resulted from increased synthesis and secretion by peritoneal-lining mesothelial cells and/or fibroblasts in response to stimulation by the tumor cells or their products. TA3/St tumor cells were universally positive for the hyaluronan receptor, CD44, whereas approximately 90% of MOT tumor cells were CD44-negative. However, the great majority of MOT or TA3/St cells that initially attached to the mesentery were strongly CD44 positive. We propose that hyaluronan-rich matrix is involved in tumor cell attachment to the mesentery possibly via interaction with tumor cell surface CD44.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8669459      PMCID: PMC1861653     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Studies on a transplantable teratoma of the mouse.

Authors:  E FEKETE; M A FERRIGNO
Journal:  Cancer Res       Date:  1952-06       Impact factor: 12.701

2.  Kinetic characterization and response to chemotherapy in a transplantable murine ovarian cancer.

Authors:  R F Ozols; K R Grotzinger; R I Fisher; C E Myers; R C Young
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

3.  Immunotherapy of ovarian carcinoma. An experimental model.

Authors:  S E Order; V Donahue; R Knapp
Journal:  Cancer       Date:  1973-09       Impact factor: 6.860

4.  The role of hyaluronic acid in intercellular adhesion of cultured mouse cells.

Authors:  C Underhill; A Dorfman
Journal:  Exp Cell Res       Date:  1978-11       Impact factor: 3.905

5.  Receptors for hyaluronate on the surface of parent and virus-transformed cell lines: binding and aggregation studies.

Authors:  C B Underhill; B P Toole
Journal:  Exp Cell Res       Date:  1981-02       Impact factor: 3.905

6.  Hyaluronic acid-stimulating activity in sera from the bovine fetus and from breast cancer patients.

Authors:  M Decker; E S Chiu; C Dollbaum; A Moiin; J Hall; R Spendlove; M T Longaker; R Stern
Journal:  Cancer Res       Date:  1989-07-01       Impact factor: 12.701

7.  Hyaluronate and invasiveness of the rabbit V2 carcinoma.

Authors:  B P Toole; C Biswas; J Gross
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

8.  Participation of hyaluronic acid in the macrophage disappearance reaction.

Authors:  B T Shannon; S H Love; Q N Myrvik
Journal:  Immunol Commun       Date:  1980

9.  Binding of hyaluronic acid to mammalian fibrinogens.

Authors:  S J Frost; P H Weigel
Journal:  Biochim Biophys Acta       Date:  1990-04-23

10.  CD44H regulates tumor cell migration on hyaluronate-coated substrate.

Authors:  L Thomas; H R Byers; J Vink; I Stamenkovic
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

View more
  28 in total

1.  Functional hierarchy of simultaneously expressed adhesion receptors: integrin alpha2beta1 but not CD44 mediates MV3 melanoma cell migration and matrix reorganization within three-dimensional hyaluronan-containing collagen matrices.

Authors:  K Maaser; K Wolf; C E Klein; B Niggemann; K S Zänker; E B Bröcker; P Friedl
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.

Authors:  H S Berner; B Davidson; A Berner; B Risberg; G B Kristensen; C G Trope; G Van de Putte; J M Nesland
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease.

Authors:  Shanli Tsui; Roshini Fernando; Beiling Chen; Terry J Smith
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

4.  Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.

Authors:  R M Peterson; Q Yu; I Stamenkovic; B P Toole
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  Mechanism of MTA1 protein overexpression-linked invasion: MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and function.

Authors:  Deivendran Sankaran; Suresh B Pakala; Vasudha S Nair; Divijendra Natha Reddy Sirigiri; Dinesh Cyanam; Ngoc-Han Ha; Da-Qiang Li; T R Santhoshkumar; M Radhakrishna Pillai; Rakesh Kumar
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

6.  Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer.

Authors:  T Miyashita; K Murata; E Hoshino; H Nishiya; Y Ono; I Akaoka; O Kunii
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

7.  Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

Authors:  Mark G Slomiany; Lu Dai; Lauren B Tolliver; G Daniel Grass; Yiping Zeng; Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

8.  Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.

Authors:  P Auvinen; R Tammi; J Parkkinen; M Tammi; U Agren; R Johansson; P Hirvikoski; M Eskelinen; V M Kosma
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

9.  CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth.

Authors:  Shailesh Singh; Vincent C Bond; Michael Powell; Udai P Singh; Harvey L Bumpers; William E Grizzle; James W Lillard
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

10.  Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression.

Authors:  H Chen; J Hao; L Wang; Y Li
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.